Download Pharmacy Curriculum Draft (NCRC); 2011
Download Pharmacy Curriculum Draft (NCRC); 2011 Download Pharmacy Curriculum Draft (NCRC); 2011
H. Revise drug therapy plans on an ongoing basis.I. Ensure continuity of pharmaceutical care to and from the acute andambulatory care patient care settings.II. Pharmacotherapy Decision-Making –A. Pursue the role of drug therapy practitioner over that of drug therapyadvisor.B. Participate in pharmacotherapy decision-making by:i. Identifying opportunities for decision-making.ii. Proactively engaging decision-making opportunities.iii. Formulating decision rationale that is the result of rigorous inquiry,scientific reasoning, and evidence.iv. Pursuing the highest levels of decision-making.v. Seeking independence in making decisions and accepting personalresponsibility for the outcomes to patients resulting from one’s decisions.vi. Personally enacting decisions2. DRUG INDUCED DISEASES3. UTILIZATION OF CLINICAL DRUG LITERATURE: Introduction,Drug literature selection, Drug literature evaluation and Drug literaturecommunication.4. ONLINE PHARMACEUTICAL CARE SERVICES ANDGLOBALIZATION.5. PROVISION OF PHARMACEUTICAL CARE IN MULTIPLEENVIRONMENTS. Professionalism, physical assessment, body substanceprecautions and the relationships between culture, race and gender topharmaceutical care.PHARM 623 PHARMACY PRACTICE-IX (ClinicalPharmacy-II) [Lab.]Cr. Hr.: 01 Marks: 50• Clerkship in the Clinical Setting. A report related to Clinical PharmacyPractices will be completed by the students and will be evaluated by theexternal examiner.• Students will also complete a report independently or in a group on a DrugUse Evaluation• Students will take the assignment tasks to enhance verbal presentation,communication, written and problem-solving skills, critical analysis of dataand provision of care through a weekly conference and projectsRecommended Books1. Roger Walker, Clinical Pharmacy & Therapeutics, Churchill Levingstone,London, 4 th Ed., 2003.2. Guard Paul, A Behavioral Approach to Pharmacy Practice, Black Well,USA, 2000.3. Herfindal Gourley, Clinical Pharmacy & Therapeutics, 4 th Ed, William&Willkins, London, 1992.74 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
4. A J Winfield, Pharmaceutical Practice, Churchill Levingstone, London,3rdEd., 1998.5. Kavin Taylor, Pharmacy Practice, 2 nd Ed, Taylor& Francis, New York,1998.6. Deborah Rosenbaun, Clinical Research Coordinator Hand Book, 4 th Ed.,Sarrison, Inc, North Carolina, USA. 2001.7. Simon Cook, Clinical Studies Management, a Practical Guide to Success,Sue Horwood Publishing limited, and West Sussex UK. 2004.8. Joseph T Dipiro, Encyclopedia of Clinical Pharmacy. Marcel DekkerPublishing, 2003.9. Joseph T Dipiro, Encyclopedia of Pharmacy. Marcel Dekker Publishing2002.10. Mellainie J Rantucci, Pharmacist Talking with Patients, 2 nd Ed,2006.11. Smith GDG and Aronson J K, Oxford Text Book of Clinical12. Pharmacology and Drug Therapy, Oxford University Press, UK, 2002.13. Hansten P and Horn J, Drug interactions. Lee & Febiger, Philadelphia,USA, 1989.PHARM 624 PHARMACEUTICS-X (Industrial Pharmacy-II) [Th.]Cr. Hr.: 03 Marks: 10001. EMULSIONS:Mechanical Equipments, Specific formulationConsiderations and Emulsion stability.02. SUSPENSIONS: Formulation of suspensions, Equipment used inpreparation and test methods for pharmaceutical suspensions.03 SEMISOLIDS:Equipment used for Ointments, Pastes, Gels and Jellies.Packaging of ointments.04 EQUIPMENTS USED FOR:Patches, Sprays, Implants, Sutures, Plastersand Sachet packing.05. STERILE PRODUCTS:Sterile area and its Classification, Ophthalmicointments, Preparation of praenterals (Building, Equipment), CompleteSterility (Aseptic area), air control, (Laminar flow etc.), air locks,Environmental monitoring methods, Sterilization, Filling/Packaging (Plasticand glass containers), Added substances (Preservatives, anti-oxidants,solubilizer, suspending agents, buffers, stabilizers etc.), Inprocess QualityControl of Parenterals (Sterility, leakage, pyrogens, clarity etc.).06. STANDARDIZATION OF PHARMACEUTICALS:An understanding ofquality assurance system adopted in pharmaceutical industry. GoodManufacturing Practices and Current Good Manufacturing Practices.07. PACKING & PACKAGING:Influence of Packaging materials, Stability,Packaging Lines, Packaging Area, Packaging Equipment.75 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
- Page 23 and 24: Experiments to demonstrate some of
- Page 25 and 26: 1990.9. Naser-ud-Din, Introduction
- Page 27 and 28: Hemorrhage and Other Causes of Hypo
- Page 29 and 30: IS 402ISLAMIC STUDIESCr. Hr.: 01 Ma
- Page 31 and 32: Publications New Delhi (1989)9) Dr.
- Page 33 and 34: PHARM 413 PHARMACEUTICS-V (Pharmace
- Page 35 and 36: e. Drug treatment of chronic inflam
- Page 37 and 38: j. Labiatae Peppermint, Thyme, Spea
- Page 39 and 40: SECOND SEMESTERPS 403PAKISTAN STUDI
- Page 41 and 42: NOTE:- Practicals of the subject sh
- Page 43 and 44: i. Drugs used for cough (Anti-tussi
- Page 45 and 46: 1. Drugs of Animal OriginGeneral in
- Page 47 and 48: Frequency Table, Diagrams, Pictogra
- Page 49 and 50: pharmaceutical students Churchill L
- Page 51 and 52: anaesthetic drugs on human and the
- Page 53 and 54: 5. Plant SteroidsIntroduction, extr
- Page 55 and 56: Adenoma, Chondroma, Fibroma, Leomyo
- Page 57 and 58: Aluminium Hydroxide, Ammonium Chlor
- Page 59 and 60: of frog. To demonstrate the effects
- Page 61 and 62: 6. Tumor Inhibitors from PlantsIntr
- Page 63 and 64: • Components of a Computer• Com
- Page 65 and 66: 1. INTRODUCTION(a) Role of Pharmaci
- Page 67 and 68: withdrawal, Detection, Management o
- Page 69 and 70: (Note: A minimum of 10 practicals w
- Page 71 and 72: 14. Ronald D Schoenwald, Pharmacoki
- Page 73: Distribution, Relationship between
- Page 77 and 78: . Factors: persistent, accumulation
- Page 79 and 80: vaccines.5. MISCELLANEOUS DETERMINA
- Page 81 and 82: 3. T V Ramabhadran, Pharmaceutical
- Page 83 and 84: 1. R Z Hussain, The Manual of Drug
- Page 85 and 86: NOTE:- Practical of the subject sha
- Page 87 and 88: PHARM 722 PHARMACY PRACTICE-XIII (C
- Page 89 and 90: 3. The Pharmacy Act 1967.4. The Poi
- Page 91 and 92: 6. Block, Roche, Soine and Wilson.
- Page 93 and 94: PHARM-D FIVE-YEAR COURSESCHEME OF S
- Page 95 and 96: Paper 4 Pharmacy Practice -VI (Fore
- Page 97 and 98: 9. PREPARATION AND PROPERTIES OF HE
- Page 99 and 100: c. Proteins and Amino acids: Brief
- Page 101 and 102: 3. PHYSICO-CHEMICAL PRINCIPLES:a. S
- Page 103 and 104: 2. Cooper and Gunns Tutorial Pharma
- Page 105 and 106: Experiences, Motivation and Emotion
- Page 107 and 108: 5. CENTRAL NERVOUS SYSTEM: Nerve Mu
- Page 109 and 110: (b)Spinal Cord — Meninges (C.S.F.
- Page 111 and 112: 1. DESCRIPTION OF STATISTICS: Descr
- Page 113 and 114: Part: B, (Communications Skills)Obj
- Page 115 and 116: 1. Writing. Advanced by Ron White.
- Page 117 and 118: effervescent, granulated salts. Har
- Page 119 and 120: Parasympathetic antagonists.f. Gang
- Page 121 and 122: (Note: A minimum of 20 practicals w
- Page 123 and 124: Sources, structure, preparation, de
H. Revise drug therapy plans on an ongoing basis.I. Ensure continuity of pharmaceutical care to and from the acute andambulatory care patient care settings.II. Pharmacotherapy Decision-Making –A. Pursue the role of drug therapy practitioner over that of drug therapyadvisor.B. Participate in pharmacotherapy decision-making by:i. Identifying opportunities for decision-making.ii. Proactively engaging decision-making opportunities.iii. Formulating decision rationale that is the result of rigorous inquiry,scientific reasoning, and evidence.iv. Pursuing the highest levels of decision-making.v. Seeking independence in making decisions and accepting personalresponsibility for the outcomes to patients resulting from one’s decisions.vi. Personally enacting decisions2. DRUG INDUCED DISEASES3. UTILIZATION OF CLINICAL DRUG LITERATURE: Introduction,Drug literature selection, Drug literature evaluation and Drug literaturecommunication.4. ONLINE PHARMACEUTICAL CARE SERVICES ANDGLOBALIZATION.5. PROVISION OF PHARMACEUTICAL CARE IN MULTIPLEENVIRONMENTS. Professionalism, physical assessment, body substanceprecautions and the relationships between culture, race and gender topharmaceutical care.PHARM 623 PHARMACY PRACTICE-IX (Clinical<strong>Pharmacy</strong>-II) [Lab.]Cr. Hr.: 01 Marks: 50• Clerkship in the Clinical Setting. A report related to Clinical <strong>Pharmacy</strong>Practices will be completed by the students and will be evaluated by theexternal examiner.• Students will also complete a report independently or in a group on a DrugUse Evaluation• Students will take the assignment tasks to enhance verbal presentation,communication, written and problem-solving skills, critical analysis of dataand provision of care through a weekly conference and projectsRecommended Books1. Roger Walker, Clinical <strong>Pharmacy</strong> & Therapeutics, Churchill Levingstone,London, 4 th Ed., 2003.2. Guard Paul, A Behavioral Approach to <strong>Pharmacy</strong> Practice, Black Well,USA, 2000.3. Herfindal Gourley, Clinical <strong>Pharmacy</strong> & Therapeutics, 4 th Ed, William&Willkins, London, 1992.74 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
Change language